Tilray Inc. (TLRY) experienced a significant surge of 15.23% in its stock price during the post-market session. This sharp increase follows the company's recent announcement of new product launches, including Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada and a broad 2025 holiday drink gift guide featuring its craft beer, spirits, RTD cocktails, and hemp-derived THC beverage portfolio.
The rally is also fueled by reports of a potential U.S. federal rescheduling of marijuana toward Schedule III, which could significantly reshape growth opportunities for Tilray's cannabis and beverage segments. Investors are optimistic that these developments could lead to improved margins and profitability for the company, despite its ongoing challenges with operating losses and dilution risks.
Comments